WASHINGTON (dpa-AFX) - Below are the earnings highlights for Rigel Pharmaceuticals Inc. (RIGL):
-Earnings: -$19.24 million in Q4 vs. -$17.20 million in the same period last year. -EPS: -$0.11 in Q4 vs. -$0.10 in the same period last year. -Analysts projected -$0.11 per share -Revenue: $18.45 million in Q4 vs. $15.40 million in the same period last year.
Copyright RTT News/dpa-AFX
RIGEL PHARMACEUTICALS-Aktie komplett kostenlos handeln - auf Smartbroker.de